Describes the initial considerations of Gilead Sciences as it designed a strategy for delivering its AIDS drug Viread to developing nations in Africa. In October 2001, Gilead Sciences received approval from the U.S. Food and Drug Administration for the co

【書誌情報】

ページ数：10ページ

サイズ：A4

商品番号：HBSP-P53A

発行日：2007/3/21

登録日：2007/8/16